Telix Pharmaceuticals Limited Adjustments For Unrealised Foreign Exchange Losses Gains
Telix Pharmaceuticals Limited (TLPPF) reported Adjustments For Unrealised Foreign Exchange Losses Gains of -$1.93 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains · last filed 2026-02-20
AUD
| Period end | Adjustments For Unrealised Foreign Exchange Losses Gains 12 month |
|---|---|
| 2024-12-31 | -17.32M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | 2.12M AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | 841.00K AUD 20-F · filed 2025-02-24 |
USD
| Period end | Adjustments For Unrealised Foreign Exchange Losses Gains 12 month |
|---|---|
| 2025-12-31 | -$1.93M 20-F · filed 2026-02-20 |
| 2024-12-31 | -$11.98M 20-F · filed 2026-02-20 |
| 2023-12-31 | $1.48M 20-F · filed 2026-02-20 |